Evidence map›Paper›PMID 20952403›Full record

ArticleNucleic acids research2011

Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells.

T Angrisano, S Sacchetti, F Natale, A Cerrato, R Pero, S Keller, S Peluso, B Perillo, V E Avvedimento, A Fusco and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Aberrant Expressions and Variant Screening ofFrontiers in pediatrics · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Toxicogenomics and cancer susceptibility: advances with next-generation sequencing.Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews · 2014
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

T AngrisanoDipartimento di Biologia e Patologia Cellulare e Molecolare and Istituto di Endocrinologia ed Oncologia Sperimentale CNR, Università degli Studi di Napoli 'Federico II' 80131 Naples, Italy.
S Sacchetti
F Natale
A Cerrato
R Pero
S Keller
S Peluso
B Perillo
V E Avvedimento
A Fusco
C B Bruni
F Lembo
M Santoro
L Chiariotti
University of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although it is well known that RET gene is strongly activated by retinoic acid (RA) in neuroblastoma cells, the mechanisms underlying such activation are still poorly understood. Here we show that a complex series of molecular events, that include modifications of both chromatin and DNA methylation state, accompany RA-mediated RET activation. Our results indicate that the primary epigenetic determinants of RA-induced RET activation differ between enhancer and promoter regions. At promoter region, the main mark of RET activation was the increase of H3K4me3 levels while no significant changes of the methylation state of H3K27 and H3K9 were observed. At RET enhancer region a bipartite chromatin domain was detected in unstimulated cells and a prompt demethylation of H3K27me3 marked RET gene activation upon RA exposure. Moreover, ChIP experiments demonstrated that EZH2 and MeCP2 repressor complexes were associated to the heavily methylated enhancer region in the absence of RA while both complexes were displaced during RA stimulation. Finally, our data show that a demethylation of a specific CpG site at the enhancer region could favor the displacement of MeCP2 from the heavily methylated RET enhancer region providing a novel potential mechanism for transcriptional regulation of methylated RA-regulated loci.

Indexed as

DNA MethylationTranscriptional ActivationCell Line, TumorChromatinDNA-Binding ProteinsDNA (Cytosine-5-)-MethyltransferasesEnhancer Elements, GeneticEnhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticHistone Deacetylase 1HumansMethyl-CpG-Binding Protein 2NeuroblastomaPolycomb Repressive Complex 2Promoter Regions, GeneticProto-Oncogene Proteins c-retChromatinDNA-Binding ProteinsDNA (Cytosine-5-)-MethyltransferasesEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHDAC1 protein, humanHistone Deacetylase 1Methyl-CpG-Binding Protein 2Polycomb Repressive Complex 2Proto-Oncogene Proteins c-retRARA protein, humanReceptors, Retinoic AcidRepressor ProteinsRetinoic Acid Receptor alphaRET protein, humanSIN3A transcription factorSin3 Histone Deacetylase and Corepressor ComplexTranscription FactorsTretinoin

Identifiers

PMID20952403
PMCPMC3064803
OpenAlexW2090634091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.